A. Rosner

Quality of life and costs associated with micronized progesterone and medroxyprogesterone acetate in hormone replacement therapy for nonhysterectomized, postmenopausal women.

N. Ryan, N. Ryan, A. Rosner, 2001, Clinical therapeutics.

Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspective.

B. O'brien, R. Goeree, T. Williamson, 2001, Clinical therapeutics.

Cost and health related quality of life consequences of multiple sclerosis

G. Torrance, G. Rice, G. Francis, 2000, Multiple sclerosis.

Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function

G. W. Torrance, M. A. Keresteci, G. Torrance, 2004, Quality of Life Research.